Sanofi

We have been named No. 7 and 1 in the Pharma Industry on TIME's list of the World's 500 Most Sustainable Companies!

Our work on environmental sustainability and resilience matters deeply to us. We work hard at being good to our planet, and our dedication to improving people’s lives goes beyond innovations in healthcare.

Learn how we’re minimizing the environmental impacts of our products and activities ➡️ http://spkl.io/604147b5d

#Sustainability

We’re proud to announce the inauguration of our second cutting-edge #Modulus facility, now open in Singapore. This milestone reinforces our commitment to innovation, sustainability, and meeting global healthcare needs with agility and responsibility.

Inaugurated by Singapore’s Minister for Health, Mr. Ong Ye Kung, this new facility is a testament to our vision for a sustainable and digitalized future in healthcare.

With advanced green technologies like solar power, green electricity, and construction materials made from recycled content, this site showcases our dedication to eco-friendly innovation.

As we celebrate this second Modulus facility, we look forward to continuing our mission to bring better health to more people, while paving the way for a sustainable future in healthcare.

#WeNeverSettle

New Year, New Look! ✨

La Maison Sanofi undergoes a dazzling transformation as we celebrate #TeamSanofi's incredible journey to the Olympic and Paralympic Games Paris 2024 🔥.

Here's to a year of breaking barriers, setting records, and reaching new heights together 🏆.

Sanofi annonce une augmentation d’1,1 milliard d’euros de ses investissements industriels, afin de créer de nouvelles capacités de bioproduction sur ses sites de Vitry-sur-Seine, Le Trait et Lyon Gerland, avec la création de 500 emplois.

Ce nouvel investissement s’ajoute aux grands projets que nous avons déjà engagés en France pour répondre aux besoins de santé publique et adapter notre outil industriel à notre portefeuille inédit de candidats médicaments et vaccins à fort potentiel.

Au total, d’ici à 2030, nous déployons un plan d’investissement de plus de 3,5 milliards d’euros pour continuer de produire en France les médicaments et vaccins essentiels pour les patients du monde entier.
Depuis la pandémie Covid-19, notre contribution à la souveraineté sanitaire française, de la R&D à la production, est et restera unique.

Le communiqué de presse : https://lnkd.in/e2d5UDiY

#santé #souverainetesanitaire #innovation #industrie #choosefrance

We’re thrilled to be ranked #3 in the 2024 Access to Medicine Index and recognized as one of the top risers this year! 🌍

This achievement reflects our efforts on access planning for projects in our R&D pipeline and the impactful work of our Global Health Unit.

Launched in 2021, our Global Health Unit is driving improved product access in LMICs, fostering partnerships, and championing an inclusive business model recognized as a “Best Practice” in the industry by the Access to Medicine Foundation.

Discover how we’re advancing global health 👉 http://spkl.io/6043fVLPN

#ATMI24 #AccessToMedicine #HealthcareAccess

[#Nomination] Charles Wolf est nommé Directeur France de Sanofi, à compter du 1er juillet 2024.
Directeur général Vaccins France depuis juillet 2022, fonction qu’il conserve, il poursuivra la transformation et la modernisation engagées par Sanofi en France pour devenir un leader mondial de l’immunologie.
Le communiqué : https://lnkd.in/ebXpAGec

This #ValentinesDay, we’re celebrating our 1-year anniversary with Team Sanofi 💜 our team of 14 inspiring athletes and coaches.

Together, we celebrate our love of sports, always pushing our limits, and never settling.

Thank you, #TeamSanofi, for inspiring us and igniting our potential on the road to the Olympic and Paralympic Games #Paris2024 🔥